Corbus Pharmaceuticals (CRBP)
Develops CRB-701 for oncology and CRB-913 for obesity.
$7.80
vs last close−0.07 (−0.95%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 49 days
EPS estimate
−$1.21
Revenue estimate
$1.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.78−$1.39−$1.44−$1.90−$1.25−$1.23−$1.81Pending
Estimate−$1.02−$1.26−$1.55−$1.80−$1.78−$1.26−$1.26−$1.21
Surprise+23.5%−10.3%+7.1%−5.6%+29.8%+2.4%−43.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———$1.1M$1.7M—$1.1M$1.7M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$1.87 | — | — |
| Sep 2028 | −$1.84 | — | — |
| Jun 2028 | −$1.81 | — | — |
| Mar 2028 | −$1.83 | — | — |
| Dec 2027 | −$1.49 | — | — |
| Sep 2027 | −$1.35 | — | — |
| Jun 2027 | −$1.27 | — | — |
| Mar 2027 | −$1.31 | — | — |
| Dec 2026 | −$1.32 | — | — |
| Nov 2026 | −$1.21 | — | — |
| Aug 2026 | −$1.26 | −$1.81 | −43.7% |
| May 2026 | −$1.26 | −$1.23 | +2.4% |
| Mar 2026 | −$1.78 | −$1.25 | +29.8% |
| Nov 2025 | −$1.80 | −$1.90 | −5.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$1.87 | — | — | $0 | — | — | — |
| Sep 2028 | −$1.84 | — | — | $0 | — | — | — |
| Jun 2028 | −$1.81 | — | — | $0 | — | — | — |
| Mar 2028 | −$1.83 | — | — | $0 | — | — | — |
| Dec 2027 | −$1.49 | — | — | $0 | — | — | — |
| Sep 2027 | −$1.35 | — | — | $0 | — | — | — |
| Jun 2027 | −$1.27 | — | — | $0 | — | — | — |
| Mar 2027 | −$1.31 | — | — | $0 | — | — | — |
| Dec 2026 | −$1.32 | — | — | $0 | — | — | — |
| Nov 11, 2026 | −$1.21 | — | — | $1.7M | — | — | — |
| Aug 6, 2026 | −$1.26 | −$1.81 | −43.7% | $1.1M | — | — | +1.8% |
| May 12, 2026 | −$1.26 | −$1.23 | +2.4% | — | — | — | +3.5% |
| Mar 9, 2026 | −$1.78 | −$1.25 | +29.8% | $1.7M | — | — | +19.2% |
| Nov 12, 2025 | −$1.80 | −$1.90 | −5.6% | $1.1M | — | — | +7.4% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 8, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 15, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 12, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 9, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 16, 2016 | |||||||
| Mar 29, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 13, 2015 |